Non-invasive model for predicting esophageal varices based on liver and spleen volume

Table 3 Univariate analysis of parameters of patients with esophageal varices and without esophageal varices

Parameter	Patients with EVs, n = 86	Patients without EVs, n = 25	P value
PVSA (mm3)	211.96 ± 69.98	175.16 ± 77.43	0.04
PVD (mm)	13.76 ± 2.48	12.94 ± 2.73	< 0.05
SVD (mm)	9.54 ± 3.21	7.16 ± 3.36	< 0.01
CTLV (cm3)	913.54 ± 312.89	1241.92 ± 34.83	< 0.01
CTSV (cm3)	787.78 ± 399.46	439.23 ± 126.25	< 0.01
SSV (cm3)	176.44 ± 31.21	195.71 ± 33.88	0.10
SLV (cm3)	1049.40 ± 188.53	1136.97 ± 174.13	0.10
Rate of liver volume change	-0.12 ± 0.55	0.12 ± 0.48	< 0.01
Rate of spleen volume change	3.46 ± 2.49	1.38 ± 2.73	< 0.01
Liver volume change (cm3)	135.85 ± 334.26	112.05 ± 280.68	0.01
Spleen volume change (cm3)	243.52 ± 163.89	611.33 ± 293.17	< 0.01
ALT (IU/L)	32.08 ± 5.44	49.44 ± 7.63	0.16
AST (IU/L)	45.05 ± 7.98	65.28 ± 8.14	0.26
LSM (KPa)	21.68 ± 5.96	23.01 ± 5.24	0.29

P < 0.05 is considered statistical significance. EVs: Esophageal varices; PVSA: Portal vein surface area; PVD: Portal vein diameter; SVD: Splenic vein diameter; CTLV: Actual liver volume measured by computed tomography; CTSV: Actual spleen volume measured by computed tomography; SSV: Standard spleen volume measured by the formula; SLV: Standard liver volume measured by the formula; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; LSM: Liver stiff measurement.